Gamma glutamyl transferase

Critical Reviews in Clinical Laboratory Sciences

Volumn 38, Issue 4, 2001, Pages 263-355

  Whitfield, J B ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; FREE RADICAL; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; LIPOPROTEIN;

ALCOHOL CONSUMPTION; ALCOHOLISM; CARDIOVASCULAR RISK; CHOLESTASIS; ENZYME DEFICIENCY; FETAL ALCOHOL SYNDROME; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENE EXPRESSION; IRON OVERLOAD; ISCHEMIC HEART DISEASE; LIVER DISEASE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; STROKE; VIRUS HEPATITIS;

EID: 0034837235     PISSN: 10408363     EISSN: None     Source Type: Journal    
DOI: 10.1080/20014091084227     Document Type: Review

References (364)

1. IFCC methods for measurement of enzymes. Part 4. IFCC methods for gamma-glutamyltransferase [(gamma-glutamyl)-peptide: Amino acid gamma-glutamyltransferase, EC 2.3.2.2]. IFCC Document, Stage 2, Draft 2, 1983-01 with a view to an IFCC Recommendation
2. Gamma-glutamyl transpeptidase
3. Structural, functional, and clinical aspects of gamma-glutamyltransferase
4. Gamma-glutamyltransferase and its isoenzymes: Progress and problems
5. Gamma-glutamyl transpeptidase. What does the organization and expression of a multipromoter gene tell us about its functions?
6. Gamma-glutamyl transpeptidase, a blood-brain barrier associated membrane protein. Splitting peptides to transport amino acids
7. Gamma-glutamyl transpeptidase: Catalytic mechanism and gene expression
8. Gamma-glutamyl transpeptidase, a glutathionase: Its expression and function in carcinogenesis
9. Patients with genetic defects in the gamma-glutamyl cycle
10. A preliminary description of the crystal structure of gamma-glutamyltranspeptidase from E. coli K-12
11. Identification, sequence, and expression of the gene encoding gamma-glutamyltranspeptidase in Bacillus subtilis
12. The disintegration of yam tuber gamma-glutamyl transpeptidase during tuber storage
13. Purified gamma-glutamyl transpeptidases from tomato exhibit high affinity for glutathione and glutathione S-conjugates
14. Purification and characterization of gamma-glutamyl transpeptidase from Ascaris suum
15. Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes
16. The organization of the gamma-glutamyl transferase genes and other low copy repeats in human chromosome 22q11
17. Gamma-glutamyl transpeptidase gene organization and expression: A comparative analysis in rat, mouse, pig and human species
18. Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene
19. Structure of the 5′ sequences of the human gamma-glutamyltransferase gene
20. A new procedure for the visualization of multiple forms of gamma-glutamyl transferase (GGT). Results in normals, patients receiving enzyme-inducing drugs and patients having liver parenchymal lesions
21. Evaluation of serum gamma-glutamyltransferase by electrofocusing, and variations in isoform patterns
22. Comparative structural and lectin-binding studies on gamma-glutamyltransferase from human adult liver, fetal liver and primary hepatoma
23. Lectin-affinity chromatography of serum gamma-glutamyltransferase in liver disease
24. Activation energy and lectin affinity chromatography of gamma-glutamyltransferase as a marker for enzyme heterogeneity
25. Multiple forms of serum gamma-glutamyltransferase. Association of the enzyme with lipoproteins
26. Complexes of serum gamma-glutamyltransferase with apolipoproteins and immunoglobulin A
27. Clearance of different multiple forms of human gamma-glutamyltransferase
28. Immunohistochemical detection of γ-glutamyl transpeptidase in normal human tissue
29. Synthesis of human gamma-glutamyl transpeptidase (GGT) during the fetal development of liver
30. Gamma-glutamyl transferase activity in fetal serum, maternal serum, and amniotic fluid during gestation
31. Species differences in the localisation of gamma-glutamyl transpeptidase immunopositive cells at the blood-brain interface
32. 1,25 - Dihydroxyvitamin D3 regulates the synthesis of gamma-glutamyl transpeptidase and glutathione levels in rat primary astrocytes
33. Gamma-glutamyl transpeptidase, a lymphoid cell-surface marker: Relationship to blastogenesis, differentiation, and neoplasia
34. Hematopoietic growth factor induction of gamma-glutamyl transferase in the KG-1 myeloid cell line
35. The activity of gamma-glutamyl transpeptidase (gamma-GT) in populations of mononuclear cells from human peripheral blood
36. Gamma-glutamyl transpeptidase, an ecto-enzyme regulator of intracellular redox potential, is a component of TM4 signal transduction complexes
37. The ectoenzyme gamma-glutamyl transpeptidase regulates antiproliferative effects of S-nitrosoglutathione on human T and B lymphocytes
38. A kinetic photometric method for serum gamma-glutamyl transpeptidase
39. Effects of storage in the cold on activity of gamma-glutamyltransferase in serum
40. Temperature-converting factors for enzymes: Comparison of methods
41. Development of radioimmunoassay for gamma-glutamyl transferase using pancreatic enzyme
42. A new fluorescence method for gamma-glutamyltransferase isoenzyme demonstration
43. DL-methionine supplementation of rice-and-bean diets affects gamma-glutamyltranspeptidase activity and glutathione content in livers of growing rats
44. Role of hepatic gamma-glutamyltransferase in the degradation of circulating glutathione: Studies in the intact guinea pig perfused liver
45. Expression of gamma-glutamyl transpeptidase mRNA after depletion of glutathione in rat liver
46. An abnormal sulphydryl compound in urine
47. Serum gamma-glutamyl transpeptidase deficiency
48. Glutathionuria: Gamma-glutamyl transpeptidase deficiency
49. Siblings with gamma-glutamyltransferase deficiency
50. Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice
51. Mice with genetic gamma-glutamyl transpeptidase deficiency exhibit glutathionuria, severe growth failure, reduced life spans, and infertility
52. Reduced glutathione, gamma-glutamylcysteine, cysteine and gamma-glutamylglutamine in gamma-glutamyltransferase deficiency
53. Altered gene expression in the liver of gamma-glutamyl transpeptidase-deficient mice
54. Gamma-glutamyl transferase (GGT) deficiency in the GGTenu1 mouse results from a single point mutation that leads to a stop codon in the first coding exon of GGT mRNA
55. Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice
56. Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase
57. Gamma-glutamyltranspeptidase-deficient knockout mice as a model to study the relationship between glutathione status, mitochondrial function, and cellular function
58. Reproductive defects in gamma-glutamyl transpeptidase-deficient mice
59. Cataract development in gamma-glutamyl transpeptidase-deficient mice
60. Altered expression of gamma-glutamyl transpeptidase in human tumors
61. Gamma-glutamyl transpeptidase immunoreactivity in benign and malignant breast tissue
62. Human ovarian tumors express gamma-glutamyl transpeptidase
63. Human and experimental hepatocarcinogenesis
64. Differential induction of gamma-glutamyl transpeptidase in primary cultures of rat and mouse hepatocytes parallels induction during hepatocarcinogenesis
65. Detection of a unique gamma-glutamyl transpeptidase messenger RNA species closely related to the development of hepatocellular carcinoma in humans: A new candidate for early diagnosis of hepatocellular carcinoma
66. Abnormal expression of hepatoma specific gamma-glutamyl transferase and alteration of gamma-glutamyl transferase gene methylation status in patients with hepatocellular carcinoma
67. Expression of gamma-glutamyl transpeptidase provides tumor cells with a selective growth advantage at physiologic concentrations of cyst(e)ine
68. Gamma-glutamyl transpeptidase mediation of tumor glutathione utilization in vivo
69. Glutathione and related enzymes in tumor progression and metastases of human melanoma
70. Gamma-glutamyl transpeptidase accelerates tumor growth and increases the resistance of tumors to cisplatin in vivo
71. Human germ cell tumors: Expression of gamma-glutamyl transpeptidase and sensitivity to cisplatin
72. Gamma-glutamyl transpeptidase is increased by oxidative stress in rat alveolar L2 epithelial cells
73. Increased gamma-glutamylcysteine synthetase and gamma-glutamyl transpeptidase activities enhance resistance of rat lung epithelial L2 cells to quinone toxicity
74. Quinones increase gamma-glutamyl transpeptidase expression by multiple mechanisms in rat lung epithelial cells
75. Nitrogen dioxide exposure activates gamma-glutamyl transferase gene expression in rat lung
76. Alveolar type II cell abnormalities and peroxide formation in lungs of rats given IL-1 intratracheally
77. Pulmonary oxidative stress response in young children with cystic fibrosis
78. Extracellular glutathione and gamma-glutamyl transpeptidase prevent H2O2 - Induced injury by 2,3 - Dimethoxy-1,4 - Naphthoquinone
79. Oxidative stress differentially regulates the expression of gamma-glutamyl transpeptidase mRNAs in the initial segment of the rat epididymis
80. Expression of gamma-Glutamyl Transpeptidase protects Ramos B cells from oxidation-induced cell death
81. Glutathione uptake and protection against oxidative injury in isolated kidney cells
82. Stimulation of glutathione absorption in rat small intestine by alpha-adrenergic agonists
83. The phagocytosis-associated respiratory burst in human monocytes is associated with increased uptake of glutathione
84. Oxidative metabolism of glutathione by gamma-glutamyl transpeptidase and peroxisome proliferation: The relevance to hepatocarcinogenesis. A hypothesis
85. Localization of oxidative damage by a glutathione-gamma-glutamyl transpeptidase system in preneoplastic lesions in sections of livers from carcinogen-treated rats
86. The role of chelators in the catalysis of glutathione-gamma-glutamyl transpeptidase-dependent lipid peroxidation by transition metals
87. Role of copper and ceruloplasmin in oxidative mutagenesis induced by the glutathione-gamma-glutamyl transpeptidase system and by other thiols
88. Promotion of glutathione-gamma-glutamyl transpeptidase-dependent lipid peroxidation by copper and ceruloplasmin: The requirement for iron and the effects of antioxidants and antioxidant enzymes
89. Gamma-glutamyl transpeptidase-dependent lipid peroxidation in isolated hepatocytes and HepG2 hepatoma cells
90. Gamma-glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system
91. Enhanced gamma-glutamyl transpeptidase expression and selective loss of CuZn superoxide dismutase in hepatic iron overload
92. Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation - A potential mechanism in atherosclerosis
93. Hydrogen peroxide produced during gamma-glutamyl transpeptidase activity is involved in prevention of apoptosis and maintenance of proliferation in U937 cells
94. 2 production and S-thiolation
95. 2 production, cell surface protein thiol oxidation and NF-kappa B activation status
96. Serum gamma-glutamyl transferase activity in volunteer blood donors
97. Health-based reference values of the Mini-Finland Health Survey. I Serum gamma-glutamyltransferase, aspartate aminotransferase and alkaline phosphatase
98. Sex- and race-related differences in liver-associated serum chemistry tests in young adults in the CARDIA study
99. Health-based reference intervals for ALAT, ASAT and GT in serum, measured according to the recommendations of the European Committee for Clinical Laboratory Standards (ECCLS)
100. Some aspects of fetal biology
101. Fetal liver function tests: Umbilical cord gamma-glutamyltransferase as a marker for fetal abnormality
102. Cord serum gamma glutamyltransferase in newborns
103. Cord blood gamma glutamyl transferase activity: Effect of gestational age, gender, and perinatal events
104. Gamma-glutamyltransferase activity in plasma: Statistical distributions, individual variations, and reference intervals
105. Serum alanine aminotransferase (ALT) and gamma-glutamyltransferase (gamma-GT) activities in north London blood donors
106. Variation in some enzymes in amniotic fluid and maternal serum during pregnancy
107. Liver function in normal pregnancy
108. Liver function tests in normal pregnancy: A prospective study of 103 pregnant women and 103 matched controls
109. Liver function tests in pre-eclampsia: Importance of comparison with a reference range derived for normal pregnancy
110. Factors affecting postnatal liver function tests
111. Serum γ-glutamyl transpeptidase and physical exercise
112. Factors contributing to intra-individual variation of serum constituents: Physiological day-to-day variation in concentrations of 10 specific proteins in sera of healthy subjects
113. Problem drinking among drunk drivers
114. Intra- and interindividual variability of carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume in teetotalers
115. Individual differences in plasma ALT, AST and GGT: Contributions of genetic and environmental factors, including alcohol consumption
116. Evidence for a substantial genetic influence on biochemical liver function tests: Results from a population-based Danish twin study
117. High serum gamma-glutamyltransferase concentrations in a family
118. Serum γ-glutamyl transpeptidase activity in liver disease
119. Gamma-glutamyl transpeptidase: A clinical and experimental study
120. Serum γ-glutamyl transpeptidase activity in liver disease
121. Role of gamma-glutamyl transpeptidase activity in the diagnosis of hepatobiliary disease
122. Diagnosis of liver diseases by laboratory results and discriminant analysis. Identification of best combinations of laboratory tests
123. Lack of value of serum gamma-glutamyl transferase in the diagnosis of hepatobiliary disease
124. Predictive values of various liver function tests with respect to the diagnosis of liver disease
125. Value of serum gamma-glutamyltransferase activity in the diagnosis of hepatobiliary disease
126. Clinical value of serum gamma-glutamyl transferase estimation in porphyria cutanea tarda
127. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: The influence of virus C infection
128. Treatment of porphyria cutanea tarda with chloroquine and its effect on associated liver disease: Retrospective analysis
129. Cimetidine in the treatment of porphyria cutanea tarda
130. Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C
131. Studies on the mechanism of the changes in serum and liver gamma-glutamyl transpeptidase activity. II. Experimental hexachlorobenzene porphyria in rabbits
132. Gamma-glutamyl transferase: A sensitive marker in experimental hexachlorobenzene intoxication
133. Health status of workers with past exposure to 2,3,7,8 - Tetrachlorodibenzo-p-dioxin in the manufacture of 2,4,5-trichlorophenoxyacetic acid: Comparison of findings with and without chloracne
134. Studies of transformer repair workers exposed to PCBs: II. Results of clinical laboratory investigations
135. Review and update of the results of the NIOSH medical study of workers exposed to chemicals contaminated with 2,3,7,8 - Tetrachlorodibenzodioxin
136. Markers of chronic alcohol ingestion in patients with nonalcoholic steatohepatitis: An aid to diagnosis
137. Non-alcoholic steatohepatitis. Report of five cases and review of the literature
138. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: A pilot study
139. Gamma-glutamyl transferase as a marker of liver transplant rejection
140. Receiver operating characteristic analysis of serum chemical parameters as tests of liver transplant rejection and correlation with histology
141. Tumour-associated isoenzymes of gamma-glutamyl transferase in the serum of patients with hepatocellular carcinoma
142. The diagnostic value of a hepatoma-specific band of serum gamma-glutamyl transferase
143. Diagnostic efficiency in discriminating liver malignancies from cirrhosis by serum gamma-glutamyltransferase isoforms
144. Separation of hepatoma-associated gamma-glutamyltransferase isoenzyme on cellulose acetate media with Triton X-100 and concanavalin A
145. Diagnostic value of serum gamma-glutamyl transferase isoenzyme for hepatocellular carcinoma: A 10-year study
146. Characterisation of γ-glutamyltranspeptidase from human hepatocellular carcinoma, compared with enzymes from normal and cirrhotic liver
147. Liver gamma-glutamyltransferase activity in viral liver disease
148. Factors predicting early response to treatment with recombinant interferon alpha-2a in chronic non-A, non-B hepatitis. Preliminary report of a long-term trial
149. Prediction of the response of chronic hepatitis C to interferon alfa: A statistical analysis of pretreatment variables
150. Treatment of chronic sporadic-type non-A, non-B hepatitis with lymphoblastoid interferon: Gamma GT levels predictive for response
151. Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon-alpha
152. Receiver operating characteristics curve analysis of factors predictive of nonresponse to interferon therapy in patients with chronic hepatitis C
153. Gamma-glutamyl transpeptidase as a response predictor when using alpha-interferon to treat hepatitis C
154. Preferential virological response to interferon-alpha 2a in patients with chronic hepatitis C infected by virus genotype 3a and exhibiting a low gamma-GT/ALT ratio
155. Factors affecting treatment responses to interferon-alpha in chronic hepatitis C
156. A model to predict long-term sustained response to interferon therapy in chronic hepatitis C
157. Ratio of γ-GT/ALT rather than ISDR variability is predictive for initial virological response to IFN-α in chronic HCV infection
158. Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C
159. Liver iron influences the response to interferon alpha therapy in chronic hepatitis C
160. Therapy of chronic hepatitis C with alpha-interferon in 182 patients. Evaluation of results, response predictive factors and side effects
161. Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosis
162. Hepatic gamma-glutamyltransferase activity in alcoholic fatty liver: Comparison with other liver enzymes in man and rats
163. Microassay of gamma-glutamyl transpeptidase in needle biopsies of human liver
164. Gamma-glutamyl transpeptidase activity in liver disease: Serum elevation is independent of hepatic GGTP activity
165. Antioxidant defenses in the bile duct-ligated rat
166. Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats
167. Altered lipid peroxidation/glutathione ratio in experimental extrahepatic cholestasis
168. Antioxidant enzyme status in biliary obstructed rats: Effects of N-acetylcysteine
169. Effects of s-adenosyl-L-methionine on hepatic and renal oxidative stress in an experimental model of acute biliary obstruction in rats
170. Biochemical events associated with ligation of the common bile duct in Wistar rats
171. Glutathione status in liver and plasma during development of biliary cirrhosis after bile duct ligation
172. Role of glutathione, lipid peroxidation and antioxidants on acute bile-duct obstruction in the rat
173. Plasma gamma-glutamyl transpeptidase elevation in patients receiving enzyme-inducing drugs
174. Activity of gamma-glutamyl transpeptidase in serum of patients receiving anticonvulsant of anticoagulant therapy
175. Serum gamma-glutamyl transpeptidase activity in patients receiving chronic phenytoin therapy
176. Factors that affect the induction of gamma glutamyltransferase in epileptic patients receiving anti-convulsant drugs
177. Altered gamma-glutamyltransferase, aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase serum activities in long-term anticonvulsive therapy - Comparison of diphenylhydantoin and carbamazepine
178. Effects of phenytoin on serum gamma-glutamyl transpeptidase activity
179. Serum concentrations and enzyme induction in epileptic children treated with phenytoin and valproate
180. Aminopyrine - An effective modifier of liver and serum gamma glutamyl transpeptidase
181. Enzyme-inducing drug combinations and their effects on liver microsomal enzyme activity in man
182. Cross-sectional study of a community with exceptional exposure to DDT
183. Gamma-glutamyl transpeptidase: A sensitive marker in DDT and toxaphene exposure
184. Evaluation of in vivo parameters of drug metabolizing enzyme activity in man after administration of clemastine, phenobarbital or placebo
185. Microsomal enzyme induction in children: The influence of carbamazepine treatment on antipyrine kinetics, 6 beta-hydroxycortisol excretion and plasma gamma-glutamyltranspeptidase activity
186. D-glucaric acid excretion in critical care patients - Comparison with 6 beta-hydroxycortisol excretion and serum gamma-glutamyltranspeptidase activity and relation to multiple drug therapy
187. A comparative study of serum F protein and other liver function tests as an index of hepatocellular damage in epileptic patients
188. The role of glutathione in the induction of hepatic gamma-glutamyltransferase by phenobarbitone
189. A requirement for low concentration of hepatic glutathione for induction of gammaglutamyltransferase by phenobarbitone
190. Gamma-glutamyl transpeptidase in chronic alcoholism
191. Serum γ-glutamyl transpeptidase activity in alcoholism
192. Gamma-glutamyl transpeptidase in alcoholism
193. Screening test for alcoholism
194. Serum gamma glutamyl transpeptidase in relation to alcohol consumption
195. Serum-gamma-glutamyltransferase in alcoholism
196. Biochemical and haematological markers of alcohol intake
197. Some laboratory correlates of drinking habits
198. Estimation of alcohol intake from laboratory results
199. Relations between reported alcohol consumption and certain biological variables in an "unselected" population
200. Alcohol consumption in a healthy population. Relationship to gamma-glutamyl transferase activity and mean corpuscular volume
201. Mean cell volume and gamma-glutamyl-transpeptidase as markers of drinking in working men
202. Dose-response relationships between drinking and serum tests in Japanese men aged 40-59 years
203. Carbohydrate-deficient transferrin as compared to other markers of alcoholism: A systematic review
204. Should we use CDT instead of GGT for detecting problem drinkers? A systematic review and meta-analysis
205. Drivers, binge drinking, and gammaglutamyltranspeptidase
206. Acute biochemical responses to moderate beer drinking
207. Effects of acute and varying amounts of alcohol consumption on alkaline phosphatase, aspartate transaminase, and gamma-glutamyltransferase
208. The effects of ethanol (0.75 g/kg body weight) on the activities of selected enzymes in sera of healthy young adults. I. Intermediate-term effects
209. Effects of ethanol (0.75 g/kg body weight) on the activities of selected enzymes in sera of healthy young adults. II. Interindividual variations in response of gammaglutamyltransferase to repeated ethanol challenges
210. Prolonged administration of ethanol to young, healthy volunteers: Effects on biochemical, morphological and neurophysiological parameters
211. Effects of moderate alcohol intake in fixed or variable amounts on concentration of serum lipids and liver enzymes in healthy young men
212. Changes in serum carbohydrate-deficient transferrin and gammaglutamyl transferase after moderate wine consumption in healthy males
213. Carbohydrate-deficient transferrin during 3 weeks heavy alcohol consumption
214. Changes in serum enzymes in moderate drinkers after an alcohol challenge
215. Decrease in serum gamma-glutamyltranspeptidase following abstention from alcohol
216. Decrease in serum gamma-glutamyltranspeptidase following abstention from alcohol in cirrhotics
217. Relationship between gamma-glutamyl transpeptidase and mean urinary alcohol levels in alcoholics while drinking and after alcohol withdrawal
218. Serum gamma-glutamyl transpeptidase and chronic alcoholism. Influence of alcohol ingestion and liver disease
219. The relationship between the development of alcoholic liver and pancreatic diseases and the induction of gamma glutamyl transferase
220. Monitoring alcoholism treatment: The appropriateness of choice between gamma GT or MCV evaluation after a short time of abstinence
221. Diagnostic value of serum gamma-glutamyl-transferase activity and mean corpuscular volume in alcoholic patients with or without cirrhosis
222. The decrease of low serum gamma glutamyl transferase during short-term abstinence
223. Longitudinal comparison of carbohydrate-deficient transferrin and gamma-glutamyl transferase: Complementary markers of excessive alcohol consumption
224. Empirical evidence of design-related bias in studies of diagnostic tests
225. The value of laboratory tests for the screening and recognition of alcohol abuse in primary care patients
226. Diagnostic tests for alcohol consumption
227. The relative value of consultation, questionnaires and laboratory investigation in the identification of excessive alcohol consumption
228. Comparison of questionnaire and laboratory tests in the detection of excessive drinking and alcoholism
229. Screening for alcoholism in a psychiatric hospital
230. Comparison of cage and mast with the alcohol markers CDT, gamma-GT, ALAT, ASAT and MCV
231. A community screening test for high alcohol consumption using biochemical and haematological measures
232. The effects of alcohol abuse on readmission for trauma
233. Comparing the diagnostic accuracy of carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean cell volume in a general practice population
234. Carbohydrate-deficient transferrin and conventional alcohol markers as indicators for brief intervention among heavy drinkers in primary health care
235. The effect of drinking intensity and frequency on serum carbohydrate-deficient transferrin and gamma-glutamyl transferase levels in outpatient alcoholics
236. Gamma-glutamyltranspeptidase and carbohydrate deficient transferrin: Alternative measures of excessive alcohol consumption
237. Evaluation of two biological markers combined as a parameter of alcohol dependency
238. Enhanced clinical utility of gamma-CDT in a general population
239. Treatment of alcohol dependence: Experiences of using biological markers in monitoring and prevention of relapse
240. Early intervention in patients with excessive consumption of alcohol: A controlled study
241. The Tromso Study: Identification of and a controlled intervention on a population of early-stage risk drinkers
242. Excessive drinking - Brief intervention by a primary health care nurse. A randomized controlled trial
243. Acamprosate appears to decrease alcohol intake in weaned alcoholics
244. Multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse
245. Does acute consumption of large alcohol amounts lead to pancreatic injury? A prospective study of serum pancreatic enzymes in 300 drunken drivers
246. Are problem drinkers dangerous drivers? An investigation of arrest for drinking and driving, serum gamma glutamyltranspeptidase activities, blood alcohol concentrations, and road traffic accidents: The Tayside Safe Driving Project
247. Graded neuropsychological impairment and elevated gamma-glutamyl transferase in chronic alcoholic men
248. Liver function tests and neuropsychologic impairment in substance abusers
249. Heavy drinking among Norwegian male drunken drivers: A study of gamma-glutamyltransferase
250. A two-year prospective study of rearrests for drunken driving
251. Convictions for drunkenness or drunken driving, sick absenteeism, and morbidity in middle-aged males with different levels of serum gamma-glutamyltransferase
252. Evaluation of serum gamma-glutamyl transferase as a screening method for excessive alcohol consumption during pregnancy
253. Gamma-glutamyl transferase and mean cell volume reveal maternal alcohol abuse and fetal alcohol effects
254. Gamma-glutamyltransferase, aspartate and alanine aminotransferases and their ratio, mean cell volume and urinary dolichol in pregnant alcohol abusers
255. Mean cell volume and gamma-glutamyl transferase are superior to carbohydrate-deficient transferrin and hemoglobin-acetaldehyde adducts in the follow-up of pregnant women with alcohol abuse
256. The prenatal detection of significant alcohol exposure with maternal blood markers
257. Effects of age and sex on biochemical responses to drinking habits
258. A multivariate assessment of alcohol consumption
259. Peripheral markers in the female "hidden alcoholic"
260. Female alcoholic outpatients and female college students: A correlational study of self-reported alcohol consumption and carbohydrate-deficient transferrin levels
261. Carbohydrate-deficient transferrin and gamma-glutamyltransferase as markers of heavy alcohol consumption: Gender differences
262. New alcohol markers - How useful are they in population studies: The Svalbard Study 1988-89
263. Conventional laboratory tests as indicators of heavy drinking in young university students
264. A comparison of carbohydrate deficient transferrin with other markers of alcohol misuse in male soldiers under the age of thirty
265. Carbohydrate-related regulation of the ethanol-induced increase in serum gamma-glutamyl transpeptidase activity in adult men
266. Ethnic differences in the consequences of alcohol misuse
267. Ethnic differences in the biological consequences of alcohol abuse: A comparison between south Asian and European males
268. The ALDH2 genotype, alcohol intake, and liver-function biomarkers among Japanese male workers
269. Elevated serum gamma glutamyl transferase (transpeptidase) and histological liver damage in alcoholism
270. Gamma-glutamyl transpeptidase activity in serum and liver in chronic alcoholism
271. Abnormal serum gamma-glutamyltranspeptidase in alcoholics. Clues to its explanation
272. Effect of drinking on correlations between biochemical variables
273. Urinary D-glucaric acid and serum hepatic enzyme levels in chronic alcoholics
274. Detection of alcohol-induced fatty liver by computerized tomography
275. Elevated liver gamma-glutamyl transferase in chronic alcoholics
276. Hepatic gamma-glutamyl transferase and hepatic fibrosis in patients with alcoholic liver disease
277. Gamma-glutamyl transpeptidase activity in liver of alcoholics and its localization
278. Duodenal gamma-glutamyltransferase activity in human biopsies: Effect of chronic ethanol consumption and duodenal morphology
279. Alcohol-induced enhancement of intestinal gamma-glutamyl transpeptidase activity in rats and humans: A possible role in increased serum gamma-glutamyl transpeptidase activity in alcoholics
280. Gamma-glutamyl transferase, intestinal alkaline phosphatase and beta-hexosaminidase activity in duodenal biopsies from chronic alcoholics
281. Significance of serum gamma glutamyl transpeptidase as a marker of alcoholism
282. Gamma-glutamyltransferase activity of liver plasma membrane: Induction following chronic alcohol consumption
283. Effect of chronic ethanol consumption on the cellular and subcellular distribution of gamma-glutamyltransferase in rat liver
284. Studies on turnover rates of rat gamma-glutamyltranspeptidase after chronic ethanol administration in vivo
285. Ethanol effects in a rat hepatoma cell line: Induction of gamma-glutamyltransferase
286. Glycosylation of gamma-glutamyltransferase is modified by ethanol in H5 - 6 hepatoma cell line
287. Hepatic gamma-glutamyltransferase activity: Its increase following chronic alcohol consumption and the role of carbohydrates
288. Increase in hepatic gamma-glutamyltransferase (GGT) activity following chronic ethanol intake in combination with a high fat diet
289. The effects of ethanol and diet on hepatic and serum gamma-glutamyltranspeptidase activities in rats
290. Basolateral gamma-glutamyl transferase ectoactivity in rat liver: Effects of chronic alcohol consumption
291. Gamma-glutamyl transferase ectoactivity in the intact rat liver: Effect of chronic alcohol consumption
292. Effects of chronic ethanol feeding on glutathione turnover in the rat
293. Increased hepatic efflux of glutathione after chronic ethanol feeding
294. Effects of ethanol feeding and withdrawal on plasma glutathione elimination in the rat
295. Effect of chronic ethanol feeding on rat hepatocytic glutathione. Compartmentation, efflux, and response to incubation with ethanol
296. Effects of chronic ethanol feeding on rat hepatocytic glutathione. Relationship of cytosolic glutathione to efflux and mitochondrial sequestration
297. Impaired uptake of glutathione by hepatic mitochondria from chronic ethanol-fed rats. Tracer kinetic studies in vitro and in vivo and susceptibility to oxidant stress
298. Effect of chronic ethanol feeding on glutathione and functional integrity of mitochondria in periportal and perivenous rat hepatocytes
299. Hepatic glutathione determination after ethanol administration in rat: Evidence of the first-pass metabolism of ethanol
300. Serum gamma-glutamyltransferase at screening and retrospective sickness days
301. Comparison of gamma-glutamyltransferase and other health screening tests in average middle-aged males, heavy drinkers and alcohol non-users
302. Identification and intervention of heavy drinking in middle-aged men: Results and follow-up of 24-60 months of long-term study with randomized controls
303. Serum cholesterol, serum triglyceride, alcohol, myocardial infarction and death (2): Necessary to pay attention to serum GT in assessment of risks of myocardial infarction and death
304. Prediction of alcohol-related harm by laboratory test results
305. Distribution, determinants, and prognostic value of gamma-glutamyltransferase for all-cause mortality in a cohort of construction workers from southern Germany
306. Elevated liver enzyme activity in construction workers: Prevalence and impact on early retirement and all-cause mortality
307. Ten-year mortality among patients with a very small or unconfirmed acute myocardial infarction in relation to clinical history, metabolic screening and signs of myocardial ischaemia
308. Gamma-glutamyltransferase: Determinants and association with mortality from ischemic heart disease and all causes
309. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM
310. Serum gamma-glutamyl transferase level in predicting hypertension among male drinkers
311. Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke
312. Distribution of, and determinants for, gamma-glutamyltransferase in a free-living population
313. The Tromso Study. Distribution and population determinants of gamma-glutamyltransferase
314. Effect of body mass and other factors on serum liver enzyme levels in men attending for well population screening
315. Body mass index and liver enzyme activity in serum
316. Liver function in moderate obesity - Study in 534 moderately obese subjects among 4613 male company employees
317. Serum gamma-glutamyl transpeptidase level and blood pressure in nondrinkers: A possible pathogenetic role of fatty liver in obesity-related hypertension
318. Distribution and population determinants of gamma-glutamyltransferase in a random sample of Sardinian inhabitants
319. Influence of age and body mass index on gamma-glutamyltransferase activity: A 15-year follow-up evaluation in a community sample
320. Fat distribution and gamma-glutamyl transferase in relation to serum lipids and blood pressure in 38-year-old Dutch males
321. Determinants of gamma-glutamyltransferase: Positive interaction with alcohol and body mass index, negative association with coffee
322. The main cause of diabetes (type II): "Normal" alcohol drinking
323. Relationship between serum gamma-glutamyl transpeptidase activity, blood pressure and alcohol consumption
324. Relationship between serum gamma-glutamyl transpeptidase activity and blood pressure in middle-aged male and female non-drinkers
325. The relationship between serum gamma-glutamyl transpeptidase levels and hypertension: Common in drinkers and nondrinkers
326. Association between hepatic steatosis, insulin resistance and hyperinsulinaemia as related to hypertension in alcohol consumers and obese people
327. Gamma-glutamyl transpeptidase, triglycerides, and enzyme induction
328. The association between serum triglycerides and gamma glutamyl transpeptidase activity in diabetes mellitus
329. Correlations of serum lipids and lipoproteins with gamma-glutamyltransferase and attitude to alcohol consumption
330. Blood lipid variability in relation to relative weight and biochemical markers of tobacco and alcohol consumption
331. Association of carbohydrate-deficient transferrin (CDT) and gamma-glutamyl-transferase (GGT) with serum lipid profile in the Finnish population
332. Gamma-glutamyl-transpeptidase in diabetics: A case control study
333. Raised liver associated enzyme activity and post-prandial bile acid concentrations in sera from treated diabetic outpatients
334. Increase of serum gamma-glutamyl transferase activity in diabetic patients is not linked to diabetes itself
335. Study on background factors associated with impaired glucose tolerance and/or diabetes mellitus
336. Gamma-glutamyl transferase in diabetic rats. The effect of insulin treatment
337. Changes in hepatic glutathione metabolism in diabetes
338. The impact of type I diabetes on rat liver gamma-glutamyltranspeptidase
339. Streptozotocin-induced diabetes increases gamma-glutamyltranspeptidase activity but not expression in rat liver
340. Two-hour glucose and insulin responses after a standardized oral glucose load in relation to serum gamma-glutamyl transferase and alcohol consumption
341. The normal values of gamma-glutamyltransferase are falsely defined up to now: On the diagnosis of hypertension, obesity and diabetes with reference to "normal" consumption of alcohol
342. Gamma-glutamyl transpeptidase and the metabolic syndrome
343. Physical activity, metabolic factors, and the incidence of coronary heart disease and type 2 diabetes
344. The effects of cigarette smoking and alcohol consumption on serum liver enzyme activities: A dose-related study in men
345. Alcohol consumption and serum liver-derived enzymes in a Danish population aged 30 to 50 years
346. Serum ferritin, gammaglutamyl-transferase and alcohol consumption in healthy middle-aged men
347. Serum gamma-glutamyltransferase in a Swedish female population. Age-related reference intervals; morbidity and prognosis in cases with raised catalytic concentration
348. Body iron stores and the risk of carotid atherosclerosis: Prospective results from the Bruneck study
349. Coronary heart disease and iron status: Meta-analyses of prospective studies
350. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women
351. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: A prospective cohort study in men in eastern Finland
352. Unexpected effects of coffee consumption on liver enzymes
353. Seven-year longitudinal population study of change in gamma-glutamyltransferase: The Tromso Study
354. Coffee and serum gamma-glutamyltransferase: A study of self-defense officials in Japan
355. Joint influence of alcohol, tobacco, and coffee on biological markers of heavy drinking in alcoholics
356. Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers
357. Coffee drinking and serum gamma-glutamyltransferase: An extended study of Self-Defense Officials of Japan
358. Association of nonalcoholic fatty liver disease with insulin resistance
359. Non-alcoholic fatty liver: Another feature of the metabolic syndrome?
360. Non-alcoholic steatohepatitis: Association with obesity and insulin resistance, and influence of weight loss
361. Fatty liver - An additional and treatable feature of the insulin resistance syndrome
362. Body fat topography as an independent predictor of fatty liver
363. Role of free radical reactions in experimental hyperlipidaemia in the pathomechanism of fatty liver